Capital Markets Day 2017

Biotec Pharmacon ASA (“Biotec”, OSE: BIOTEC) announces today the company´s strategic update and 2020 ambitions at Biotec´s Capital Markets Day 2017 (CMD). The company is currently building revenues in 4 different markets with a 2020 revenue ambition of NOK 150-200 million where partnerships and value creating activities will be key priorities. – Biotec has over … Continued ›

Biotec Pharmacon presents at Anglonordic Life Science Conference

Biotec Pharmacon ASA (OSE:BIOTEC) will present at the Anglonordic Life Science Conference taking place in London today, Thursday 19. May Estimated start of the presentation will be at 11.45. Speaker will be CEO Svein W. F. Lien. Please find the presentation attached. Anglonordic May 2016 For further information Børge Sørvoll CFO +47 952 90187 borge.sorvoll@biotec.no  

Pareto Securities Health Care Seminar 2015

Svein Lien is presenting at Pareto Securities Health Care Seminar 2015 on 28th August 2015. The presentation will start at approximately 1330. Download a copy of the presentation.

Presentation of Q2 2015 results

Biotec Pharmacon presents its report for the second quarter 2015 on Thursday, 13 August The presentation will be given by CEO Svein Lien. The presentation starts at 08:30 am and will be in Norwegian. Venue: Hotell Continental, Stortingsgata 24, Oslo. The presentation can also be followed as a live webcast from Hegnar TV and it will be … Continued ›

Presentations from Carnegie Healthcare seminar and InvestorDagen

Biotec Pharmacon presents at the Carnegie Healthcare seminar in Stockholm, Thursday 12 March 2015 and at InvestorDagen, København, 18 March 2015 Speaker: CEO Svein W. F. Lien. Download the Carnegie Healthcare seminar presentation Copenhagen 18-03-2015 presentation

Browse archive